Senior insider sale
Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$231.6K
7.97K shares
What this filing means
JONES CECILIA plans to sell 7.97K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $231.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001439222-26-000027
Officer· Chief Financial Officer
Since Mar 2026
7.97K
Shares to sell
$231.6K
Approx. market value
5.04K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
3/2/2026
5.04KTotal acquired5.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units Not Applicable | 5.04K | — |
| Total | 5.04K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.93K
Market value
$79.4K
12/30/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
5.04K
Market value
$152.2K
3/2/2026
Total
Units
7.97K
Value
$231.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/30/2025 | 2.93K | $79.4K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 5.04K | $152.2K | Nasdaq | Planned |
| Total | 7.97K | $231.6K | ||